Improve ECMO outcomes with TCD monitoring in ECMO from MedTech Edge, providing advanced and reliable cerebral hemodynamic solutions across Australia.
Neurological complications remain a major concern for patients receiving extracorporeal membrane oxygenation (ECMO), often resulting from altered cerebral perfusion. Maintaining stable cerebral hemodynamics is essential to prevent irreversible brain injury during this life-sustaining therapy. TCD monitoring in ECMO offers clinicians real-time insight into cerebral blood flow, supporting early detection of ischemic or embolic events that could compromise neurological outcomes.
Extracorporeal membrane oxygenation sustains vital organ function in cases of severe cardiac or respiratory failure. However, its complex physiological effects on cerebral circulation demand constant vigilance. Transcranial Doppler (TCD) ultrasonography provides a non-invasive method to evaluate cerebral blood flow velocity and vascular resistance in real time.
An international 2024 Critical Care consensus highlights that multimodal neuromonitoring—specifically including TCD—helps detect cerebral hypoperfusion and microembolic activity in ECMO, enabling parameter adjustments that improve neurological safety and outcomes. By interpreting flow waveforms, clinicians can detect perfusion deficits, embolic signals, or changes in intracranial pressure before critical damage occurs; the integration of TCD monitoring in ECMO supports more informed, data-driven decisions.
Cerebral blood flow can fluctuate significantly during ECMO therapy. Through precise Doppler measurements, TCD provides quantitative data on:
• Mean Flow Velocity (MFV): Indicates adequacy of cerebral perfusion.
• Pulsatility Index (PI): Reflects vascular compliance and downstream resistance.
• Flow Symmetry: Identifies potential vascular occlusions or asymmetrical perfusion.
These insights allow clinicians to tailor ECMO flow parameters, oxygenator function, and arterial pressures to maintain optimal cerebral oxygenation.
Continuous cerebral monitoring has become a critical adjunct in ECMO-supported care to minimise neurological risk and guide hemodynamic management. Through advanced Doppler evaluation, TCD monitoring in ECMO provides clinicians with real-time insights that transform neurological surveillance into a data-driven process.
Key clinical advantages include:
• Early ischemia and emboli detection: TCD enables prompt identification of perfusion deficits and embolic activity, allowing immediate corrective intervention.
• Continuous autoregulation tracking: Cerebrovascular reactivity monitoring guides clinicians in maintaining optimal perfusion stability under varying physiological conditions.
• Real-time cannulation guidance: Continuous Doppler feedback ensures safe cerebral perfusion during ECMO initiation and withdrawal phases.
• Prevention of hypoxic complications: Real-time hemodynamic data support proactive oxygenation management to prevent cerebral hypoxia.
• Flow differentiation in veno-arterial (VA) and veno-venous (VV) ECMO: TCD distinguishes between antegrade and retrograde flow dynamics, improving cerebral oxygenation balance across both ECMO modalities.
At MedTech Edge, we deliver high-precision transcranial Doppler systems engineered to enhance cerebral monitoring in ECMO-supported patients across Australia. Proudly introducing the Dolphin/XF headset, the X-Factor in TCD robotic solutions, these systems feature sophisticated algorithms that obtain bilateral TCD insonations in just a few seconds and continually track target vessels.
Designed for both short- and long-term use in anaesthesia, intensive care, or dedicated TCD labs, this technology supports clinicians with dependable, data-rich insights. Integrating TCD monitoring in ECMO with our advanced systems allows healthcare teams to improve diagnostic confidence, reduce neurological risk, and ensure superior patient outcomes.
Cerebral protection remains central to safe and effective ECMO therapy, and TCD technology continues to redefine neurological precision. With our expert-driven innovations at MedTech Edge, Australian clinicians gain the accuracy and reliability needed to deliver the highest standards of neuromonitoring care.
Contact us to learn how our next-generation TCD monitoring in ECMO solutions empowers hospitals to achieve safer, data-driven neurological care.
Related Blog Article: Transcranial Doppler (TCD) for Subarachnoid Haemorrhage—Early Vasospasm Alerts for Neurocritical Care
MedTech Edge supports clinicians in Australia with the TCD bubble study. The Dolphin/XF system delivers speed, comfort, and accuracy in PFO screening.
Detecting a patent foramen ovale (PFO) is vital in patients with unexplained stroke, transient ischemic attack (TIA), or other neurological conditions linked to right-to-left shunts. While transesophageal echocardiography (TEE) has long been used for confirmation, it is semi-invasive, time-consuming, and often uncomfortable. The TCD bubble study provides a safe, non-invasive alternative that enables rapid, repeatable screening without the need for sedation or specialised imaging suites.
The TCD bubble study has been performed for decades, but its accuracy and ease of use have often relied on operator skill and the stability of probes. Maintaining consistent signals on both sides of the brain can be challenging, especially during patient manoeuvres such as Valsalva. These limitations have historically reduced efficiency and made reproducibility more difficult.
To overcome these challenges, manufacturers have developed robotic, automated bilateral scanning systems that streamline probe placement and improve signal acquisition. These devices enable clinicians to complete tests more quickly, consistently, and with greater patient comfort. Among them, the Dolphin/XF robotic probe system from MedTech Edge stands out for its speed, ease of use, and targeted design for bubble study procedures.
The Dolphin/XF brings several innovations to the table that make it especially suited to complex functional tests like PFO detection:
• Automated Bilateral Scanning: Robotic probes position and maintain stable contact on both sides of the head, reducing operator dependence and improving reproducibility.
• Rapid Signal Acquisition: Bilateral scanning can be completed in seconds, saving time during contrast injections and minimising patient discomfort.
• Comfort and Stability: The lightweight headset allows patients to be seated, lying down, or even standing, offering flexibility in clinical settings such as ICUs or stroke units.
• Specialty Testing Modes: Dedicated protocols for bubble studies, vasomotor reactivity (VMR), and emboli detection make it easier to run targeted, repeatable assessments.
• Advanced Visualisation: High-resolution depth “heat maps” help clinicians quickly identify optimal signal depths, improving accuracy and interpretation.
Many systems can perform a TCD bubble study, but the Dolphin/XF is recognised as a flagship option for rapid, non-invasive PFO screening. Its robotic bilateral scanning reduces operator dependence and helps deliver consistent, repeatable results. By addressing common challenges such as probe stability and patient cooperation, the Dolphin/XF makes bubble study procedures more reliable and efficient.
The choice of diagnostic equipment depends on factors such as patient volume, workflow, and staff expertise. The Dolphin/XF is designed to meet these needs by combining speed, comfort, and advanced testing protocols in one system. This balance of innovation and practicality allows healthcare providers to strengthen their screening processes and achieve better outcomes for patients.
The TCD bubble study remains an essential tool for early detection of PFO and other right-to-left shunts, providing a fast, patient-friendly alternative to more invasive imaging techniques. With the Dolphin/XF, clinicians can achieve greater efficiency, accuracy, and comfort in their screening process, ultimately supporting better outcomes for patients.
As part of a comprehensive TCD portfolio, the Dolphin/XF reflects how our team at MedTech Edge continues to advance neurological diagnostics — combining innovation with practical solutions for modern healthcare settings.
Contact us at MedTech Edge today to see how we can support your PFO screening and diagnostic programs.
Related Blog Article: Transcranial Doppler (TCD) for Subarachnoid Haemorrhage—Early Vasospasm Alerts for Neurocritical Care
Improve patient outcomes with MedTech Edge in Melbourne through reliable advanced TCD devices for cerebral autoregulation and CO₂ vasomotor reactivity.
Importance of Assessing Cerebral Autoregulation in Critical Care
Impaired cerebral autoregulation places patients with traumatic brain injuries, strokes, or post-surgical complications at greater risk of adverse outcomes. Poor regulation of blood flow can result in either inadequate perfusion or elevated intracranial pressure, both of which may cause additional neurological damage. Early and precise evaluation is essential to prevent secondary injury and improve recovery prospects.
Unstable cerebral perfusion can result in secondary brain injuries that may be preventable with appropriate monitoring. Assessing CO₂ vasomotor reactivity allows healthcare professionals to detect early changes in vascular response, supporting rapid clinical decisions. Such proactive measures significantly enhance patient safety and improve the chances of recovery.
Transcranial Doppler (TCD) is a non-invasive diagnostic tool that measures blood flow velocity within the cerebral arteries. Its real-time feedback enables clinicians to evaluate vascular responses immediately and make informed adjustments to patient care.
TCD remains a preferred method due to its portability and bedside compatibility. Its ability to continuously monitor cerebral circulation provides valuable information without exposing patients to additional risks. Understanding how CO₂ levels influence vessel dilation and constriction is central to the accurate interpretation of the data collected.
Accurate CO₂ vasomotor reactivity testing relies on a structured approach to ensure precise and consistent results. Following these steps helps clinicians optimise cerebral Doppler ultrasound measurements and support informed decision-making in neurocritical care.
• Patient Preparation – Position the patient comfortably and establish baseline readings under stable conditions while ensuring all monitoring systems are accurately calibrated.
• CO₂ Manipulation – Use controlled hyperventilation or administer CO₂-enriched gas to create measurable changes in cerebral blood flow.
• Data Collection – Record mean blood flow velocities with Transcranial Doppler during both baseline and altered CO₂ states for reliable comparisons.
• Interpretation and Assessment – Calculate the vasomotor reactivity index and compare against set thresholds to identify patients at higher risk requiring closer monitoring or intervention.
Continuous monitoring with cerebral Doppler ultrasound provides essential real-time data that guide treatment decisions for critically ill patients. By combining Transcranial Doppler measurements with other modalities, such as intracranial pressure monitoring and multimodal neuromonitoring, clinicians gain a comprehensive understanding of cerebral health.
Featured transcranial Doppler Products from MedTech Edge:
• Dolphin Max – A fully integrated cerebral Doppler ultrasound unit with an internal battery, ideal for mobile use and bedside neurovascular monitoring.
• Dolphin 4D – Offers advanced four-dimensional Doppler imaging for precise vessel visualisation and blood flow assessment.
• Dolphin IQ – A modular TCD component designed to upgrade existing diagnostic setups without needing a full system replacement.
• Dolphin XF – Robot – A robotic bilateral TCD system that automates probe positioning for consistent and continuous dual-hemisphere monitoring.
Combining cerebral autoregulation and CO₂ vasomotor reactivity testing allows clinicians to deliver superior care and reduce risks for vulnerable patients. At MedTech Edge, we provide comprehensive, customisable solutions for advanced neurovascular monitoring. Our range of Transcranial Doppler systems and accessories is designed to meet the diverse needs of hospitals and specialised care units.
Contact our team today to learn how we can support your vascular diagnostic services with innovative and reliable technology.
Related Blog Article: Dolphin TCD Machines for Brain Death Assessment – Available at MedTech Edge for AU & NZ
Support Australian ICU teams with MedTech Edge’s reliable Transcranial Doppler devices for safe and accurate monitoring of traumatic brain injury patients.
Transcranial Doppler for traumatic brain injury provides real-time insights into cerebral blood flow, supporting timely decisions in critical care. This non-invasive tool allows ICU teams to monitor brain function at the bedside without added patient risk. Early detection of blood flow disturbances improves outcomes and guides treatment strategies for complex neurological cases.
Traumatic brain injury disrupts the normal regulation of blood supply to brain tissue, increasing the chance of secondary damage such as ischemia. These disturbances compromise oxygen delivery and worsen neurological outcomes if not addressed promptly. Detecting changes early is vital to reducing the risk of permanent impairment.
ICU teams often struggle to track cerebral perfusion changes accurately using traditional monitoring techniques. Fluctuating intracranial pressures and limited visibility into cerebral hemodynamics make timely intervention difficult. Transcranial Doppler offers a direct, real-time method to assess these changes and guide immediate care.
Transcranial Doppler uses ultrasound technology to measure blood flow velocity within major cerebral arteries. High-frequency sound waves travel through the skull, reflecting off moving red blood cells to generate precise data. This process provides clinicians with continuous feedback on cerebral circulation.
The technique is non-invasive, portable, and safe for repeated use in critical care environments. Clinicians can quickly obtain measurements without moving unstable patients. Parameters such as flow velocity and cerebrovascular resistance offer valuable insight into cerebral function.
At MedTech Edge, we supply advanced TCD devices, including:
• Dolphin Max
• Dolphin 4D
• Dolphin IQ
• Dolphin XF – Robot
Bedside TCD monitoring enhances critical care by providing immediate, accurate data. This supports rapid decision-making and helps prevent secondary brain injuries caused by delayed treatment.
Key benefits include:
• Real-time decision-making: Detect cerebral blood flow changes instantly to guide urgent interventions.
• Non-invasive and repeatable: Monitor patients frequently without introducing additional risks.
• Portability: Perform scans directly at the bedside, reducing the need to move critical patients.
• Guidance for treatment: Guide treatment decisions, medication use, and breathing support.
• Early detection: Identify vasospasm and hypoperfusion before they escalate into severe complications.
Incorporating TCD into ICU protocols improves safety and recovery rates for traumatic brain injury patients by detecting subtle cerebral changes early and preventing secondary complications. This real-time data supports informed clinical decisions and more effective treatments. With proper training and technology adoption, TCD is set to become a standard tool in modern neurocritical care, driving better patient outcomes.
A study in the Asian Journal of Neurosurgery revealed that patients with abnormal TCD readings, such as flow velocities above 120 cm/s or below 35 cm/s, had a 3.87 times higher risk of poor outcomes and a 9.96 times greater risk of mortality, reinforcing the need for precise bedside cerebral flow monitoring in ICU care.
At MedTech Edge, we provide trusted transcranial Doppler solutions to improve traumatic brain injury management. Our bedside monitoring tools help ICU teams act quickly, protect brain function, and enhance recovery. Supported by global partners and proven expertise, we deliver innovative technology that supports exceptional patient outcomes.
Contact us today to explore how our solutions can help transform your critical care practices.
Related Blog Article: Exploring and Comparing the Various Transcranial Doppler Applications in Neurology and Stroke Management
MedTech Edge provides leading peripheral vascular diagnostics in Australia & New Zealand, offering ABI, PVR & Doppler systems for early PAD detection.
Peripheral Artery Disease (PAD) occurs when plaque builds up in the arteries supplying the legs, leading to reduced blood flow and increased cardiovascular risk. This condition is common among older adults but also affects individuals with specific lifestyle and health-related factors. Early warning signs include leg pain during walking, slow-healing wounds on the feet, or numbness and coldness in the lower limbs. Identifying these symptoms early ensures timely referral for further vascular evaluation.
Early diagnosis of PAD depends on reliable vascular testing, which provides clinicians with measurable data beyond physical examination alone. Delayed detection often results in advanced disease requiring surgical intervention, whereas timely screening helps guide conservative treatment strategies. These methods allow practitioners to monitor disease progression and tailor management plans, ultimately reducing the risk of severe complications such as amputation or cardiovascular events.
The value of non-invasive testing in PAD is supported by evidence. The study “Noninvasive physiologic vascular studies: A guide to diagnosing peripheral arterial disease” highlights how physiologic vascular studies such as ABI, Doppler waveforms, and PVR offer reliable insights into arterial function and disease progression (Sibley et al., 2017).
ABI is one of the simplest yet most effective tools in peripheral vascular diagnostics. It compares blood pressure measurements taken at the ankle with those in the arm, providing a reliable indicator of arterial obstruction. Abnormal readings highlight impaired blood flow and support early referral for further imaging.
The main advantages of ABI testing are:
• Non-invasive – Conducted using standard blood pressure cuffs and Doppler probes, with no patient discomfort.
• Quick and efficient – Results are available within minutes, making it suitable for routine screening.
• Reliable baseline tool – Detects early changes in circulation before symptoms escalate.
• Cost-effective – A low-cost method that provides high clinical value in primary care and specialist settings.
PVR testing complements ABI by analysing volume changes in the limb during the cardiac cycle. This approach evaluates the quality of blood flow through waveform interpretation, highlighting arterial narrowing or occlusion. When combined with ABI, PVR enhances diagnostic accuracy, offering clinicians a broader understanding of circulatory health in the lower extremities.
Doppler ultrasound adds a real-time imaging dimension to peripheral vascular diagnostics. Using sound waves to map arterial flow enables clinicians to detect narrowing or blockages with precision. Unlike pressure-based tests, Doppler provides direct visual evidence of the severity and location of disease.
The primary benefits include:
• Real-time imaging – Offers immediate insights into arterial conditions.
• Detailed localisation – Pinpoints the exact site of narrowing or blockage.
• Non-invasive and safe – No radiation or invasive procedure required.
• Supports treatment planning – Informs whether surgical or non-surgical intervention is required.
• Effective for follow-up – Tracks changes in arterial health after treatment or lifestyle modification.
Accurate PAD screening through ABI, PVR, and Doppler ultrasound enables earlier intervention, reducing complications and improving patient outcomes. At MedTech Edge, we provide advanced peripheral vascular diagnostics with Falcon systems that are comprehensive, adaptable, and designed for diverse clinical needs. Our ultramodern non-invasive technologies make vascular screening precise, scalable, and clinically reliable.
Contact us today to enhance your diagnostic service.
Related Blog Article: Pulse Volume Recording (PVR): Improve Non-Invasive PAD Diagnosis with the Falcon
